Charusheela Andaz

home / authors / charusheela-andaz

Articles

6 Treatment Outcomes of the KEYNOTE-522 Regimen in an Ethnically Diverse Patient Population

6 Treatment Outcomes of the KEYNOTE-522 Regimen in an Ethnically Diverse Patient Population

Mukuhi Ng’ang’a;Susan Burdette-Radoux, MD;Abhigna Kodali;Gene Sobol;Michael Silver;Charusheela Andaz;Patrick I. Borgen, MD;Joshua Feinberg
August 27th 2024
58 Prospective Longitudinal Assessment of Financial Toxicity Among Breast Cancer Patients

58 Prospective Longitudinal Assessment of Financial Toxicity Among Breast Cancer Patients

Jonathan Klein;Joshua Feinberg;Mukuhi Ng’ang’a;Ashley Anderson;Vijaya Natarajan;Pasang Sherpa;Fleure Gallant;David Berlach;Ezekiel Sanchez;Charusheela Andaz
May 12th 2024
29 The Effect of Personality Type on Satisfaction With Information Exchange in Breast Cancer Patients

29 The Effect of Personality Type on Satisfaction With Information Exchange in Breast Cancer Patients

Vijayashree Murthy;Dana Borgen;Joshua Feinberg;Kristin E. Rojas;Vijaya Natarajan;Yocasta Mejia;Michael Silver;Charusheela Andaz;Donna-Marie Manasseh
May 6th 2022

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
The Hidden Danger Unveiling the Connection Between Multiple Myeloma and Pleural Effusion
Published: November 8th 2024 | Updated: November 21st 2024
The Hidden Danger Unveiling the Connection Between Multiple Myeloma and Pleural Effusion
Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship
Published: November 7th 2024 | Updated: November 21st 2024
Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship
Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?
Published: November 12th 2024 | Updated: November 21st 2024
Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?